Euglena Co., Ltd. (EGLNF)

Market Cap	311.15M -24.4%
Revenue (ttm)	321.90M +7.8%
Net Income	-1.06M
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	0.01 (0.57%)
Ex-Dividend Date	Dec 29, 2025

Volume	105
Open	2.262
Previous Close	3.060
Day's Range	2.262 - 2.262
52-Week Range	2.262 - 3.060
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About Euglena

Euglena Co., Ltd. engages in the research, development, production, and sale of microalgae in Japan. It operates through there segments: Healthcare Business; Biofuel Business; and Other businesses. The company manufactures and sells health foods and cosmetics utilizing microalgae, such as euglena and chlorella. In addition, the company develops biofuel technology and environmental related technology for microalgae and industrial waste oil; development and research in agriculture business comprising feed and fertilizer, bioinformatics, and socia...

• Industry: Pharmaceutical Preparations
• Founded: 2005
• Employees: 793
• Stock Exchange: OTCMKTS
• Ticker Symbol: EGLNF

Financial Performance

In 2025, Euglena's revenue was 50.37 billion, an increase of 5.78% compared to the previous year's 47.62 billion. Losses were -805.00 million, 23.8% more than in 2024.

Financial numbers in JPY

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Sep 25, 2026

Data Sources Report a data error